Iota Biosciences and its parent company Astellas Pharma maintain exclusive commercialization pipelines for ultrasonic implants delivering bioelectronic stims.
No event time was recorded for this claim — the text gave nothing to anchor it to, and a guessed date would be worse than none.
Standing
lens: Evidence-weighted Structural
No belief has been computed for this claim under Evidence-weighted yet.
What bears on it
Nothing supports or challenges this claim yet — untested, which is not the same as refuted.
Voices
- reddit.com independent
Voices are counted, never weighed. How many people say a thing is structure worth seeing; it is not, by itself, a reason to believe it.
What the documents actually said
The verbatim text each extraction read before resolving it into this canonical claim. Quoted, never republished.
- Iota Biosciences and its parent company Astellas Pharma maintain exclusive commercialization pipelines for ultrasonic implants delivering bioelectronic stims.
Commercial developer Iota Biosciences and parent company Astellas Pharma maintain exclusive commercialization pipelines for ultrasonic implants delivering bioelectronic stims.
Sources
- Ultrasonic Bioelectronics vs. Airborne Sensing: StimDust and the Legacy of Smart Dust [DARPA BAA 97-43] cited evidence
Who and what it involves
Origin: extracted from Ultrasonic Bioelectronics vs. Airborne Sensing: StimDust and the Legacy of Smart Dust [DARPA BAA 97-43] · 2026-09-06 19:42